The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 
Research
Filter by Region, Sector, or Focus
UVA professors and administrators secured a nearly $7.6 million contract from the Defense Advanced Research Projects Agency to detect broad-spectrum cyber threats almost immediately after they are launched.
UVA Today
PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data stream
The Wall Street Journal
UVA Professor Shawn Russell helps those with disabilities take on skiing, proving that biomechanics research has real-life applications that can change lives for the better in Virginia and beyond.
Illimitable
PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data stream
The Wall Street Journal
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
Charlottesville Tomorro…
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.
UVA Today
NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.
UVA Today
Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.
UVA Today
UVA leaders celebrated the announcement of Amazon's decision to locate a major headquarters function in Virginia as a significant opportunity to increase our contributions to the state and to collaborate with additional Virginia universities to creat
UVA Today
A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.
WMRA
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
Charlottesville Tomorro…